The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Revenue increased 11.4 per cent to Rs. 8,545 crore
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Subscribe To Our Newsletter & Stay Updated
